Radiation therapy for upper esophageal cancer real-world study
Part of Cancer, Digestive system clinical trials.
This trial is studying standard radiation therapy for people with esophageal cancer in the neck or upper chest (cervical and upper thoracic). It includes those who cannot or choose not to have surgery, and it aims to gather real-world results to improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with esophageal cancer (confirmed by biopsy).
- Your tumor is in the upper part of the esophagus (neck or upper chest).
- Your cancer has not spread to other organs (no distant metastasis).
- You will receive standard radiation therapy (once a day, small dose fractions) as your main treatment, possibly with chemo or other drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, more precise type of radiation therapy for esophageal cancer that adjusts the treatment in real time using a special CT scan. It aims to deliver a stronger dose to the tumor while sparing healthy tissue, which could improve outcomes.
This trial tests if adding radiation therapy after endoscopic surgery (ESD) helps people with early-stage esophageal cancer that had certain high-risk features, like deeper invasion or positive margins. It aims to improve outcomes for those who didn't get a complete cure with surgery alone.
This trial tests whether adding radiation therapy to a standard treatment (immunotherapy plus chemotherapy) can help people with advanced esophageal cancer that has spread to up to two organs. The goal is to see if the combination improves outcomes.
This trial tests a new approach for advanced esophageal cancer that combines targeted radiation, immunotherapy, and chemotherapy. It aims to see if skipping radiation to certain lymph nodes can improve outcomes while reducing side effects.
This trial tests whether low-dose radiation can help people with advanced esophageal cancer that has stopped responding to standard chemotherapy plus immunotherapy. It aims to see if adding radiation can shrink tumors or slow the disease.
This trial tests whether adding radiotherapy can help people with metastatic esophageal cancer that has already responded well to initial treatment with immunotherapy and chemotherapy. It may offer a way to improve outcomes for those whose cancer has not progressed after 2-4 cycles of first-line treatment.
Hear when a new Esophageal Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.